We are live on
!
Find out more
SELLAS Life Sciences
14 hedge funds and large institutions have $2.1M invested in SELLAS Life Sciences in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
4,345% more call options, than puts
Call options by funds: $489K | Put options by funds: $11K
1% more capital invested
Capital invested by funds: $2.07M → $2.1M (+$24.5K)
0.01% less ownership
Funds ownership: 0.2% → 0.18% (-0.01%)
13% less funds holding
Funds holding: 16 → 14 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Holders
14
Holders Change
-2
Holders Change %
-12.5%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
–
Closed
5
Calls
$489K
Puts
$11K
Net Calls
+$478K
Net Calls Change
+$12K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$1.09M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$567K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$54.8K |
| 4 |
BlackRock
New York
|
+$43.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$6.58K |
Top Sellers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.07M |
| 2 |
APA
American Portfolios Advisors
Holbrook,
New York
|
-$1.92K |